Level 4 Pathogens
Managing Pediatric Respiratory Presentations
Public education resources have been developed to guide parents/guardians of the options available to them when a child is experiencing mild to moderate cold or flu symptoms. These include awareness of primary care options and walk-in clinics, including some after-hours and evening/weekend options.
Managing Pediatric Respiratory Presentations: Emergency Department
Memo: Management of Respiratory Presentations in the Pediatric Population – Guidance for Emergency Departments and Urgent Care Centres
Medical Staff Bylaws
Information relevant to medical staff practicing within Shared Health, including Health Sciences Centre Winnipeg (HSC):
Patient Info Sheets
Serious adverse drug reaction and medical device incident reporting
On Dec. 16, The Protecting Canadians from Unsafe Drugs Act (Vanessa’s Law) came into effect in Canada. The law introduces the requirement for mandatory reporting of serious adverse drug reactions and medical device incidents by hospitals.
The law improves Health Canada’s ability to:
- collect safety information;
- take appropriate action (such as a label change or a product recall) when a serious health risk is identified; and
- increase transparency (by sharing more information).
Who is required to report?
The requirement for mandatory reporting applies to all hospitals.
- The requirement also applies to outpatient clinics if they are legally part of the hospital.
- Health-care institutions that are not defined as hospitals, such as private clinics or long-term care facilities (e.g. nursing homes), continue to be encouraged to report on a voluntary basis.
- ADR/MDI reporting general SOPs for staff
- ADR/MDI reporting SOPs for Site Representative and Quality Improvement and Patient Safety (QIPS)
- Basic reporting instructions for adverse drug reaction in RL
For more information about Vanessa’s Law, visit the Canadian Patient Safety Institute at https://www.patientsafetyinstitute.ca/en/toolsResources/Vanessas-Law/Pages/default.aspx.